Pathogen Adherence to Carbohydrate Database (PACDB)

PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.

Database Last Updated
Pathogen Adherence to Carbohydrate Database (PACDB) June 1, 2016
Species Pathogen Adherence Molecule Ligand Name Ligand Feature Target Source Glycan Sequence Binding ▲ PubMed ID
K88ab/K88ac/K88ad
Fuc-nLc6 (V3)
Oligoglycosylceramides
Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
Not Binding
K88ab/K88ac/K88ad
Fuc-nLc6 (VI2)
Oligoglycosylceramides
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Lectin-hemagglutinin adhesins
Gb4 (Globoside; Globotetraose; P antigen)
Oligoglycosylceramides
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Lectin-hemagglutinin adhesins
Gb4 (Globoside; Globotetraose; P antigen)
Oligoglycosylceramides
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
PsaA/B (pH-6 antigen)
Gb4 (Globoside; Globotetraose; P antigen)
Oligoglycosylceramides
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
PsaA/B (pH-6 antigen)
Gb5 (Forssman glycolipid)
Oligoglycosylceramides
GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
P-fimbriae
Gb4 (Globoside; Globotetraose; P antigen)
Oligoglycosylceramides
GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Cholera toxin
H5 type 2 pentaglycosylceramide (neolacto-series)
Oligoglycosylceramides
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Cholera toxin
Asialo-GM2 (Gangliotriosylceramide; GgO3)
Oligoglycosylceramides
GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Cholera toxin
nLc4Cer (Neolactotetraosylceramide; Paragloboside)
Oligoglycosylceramides
Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Displaying entries 1641 - 1650 of 1840 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01